Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystinuria | 3 | 2020 | 19 | 1.070 |
Why?
|
| Hyperoxaluria, Primary | 2 | 2022 | 22 | 1.060 |
Why?
|
| Hyperoxaluria | 2 | 2022 | 32 | 1.040 |
Why?
|
| Spinal Dysraphism | 7 | 2022 | 161 | 0.950 |
Why?
|
| Urinary Tract | 4 | 2021 | 309 | 0.870 |
Why?
|
| Nephrolithiasis | 5 | 2022 | 110 | 0.690 |
Why?
|
| Kidney Tubules, Collecting | 5 | 2017 | 178 | 0.630 |
Why?
|
| Urologic Diseases | 1 | 2019 | 243 | 0.570 |
Why?
|
| Renal Replacement Therapy | 8 | 2012 | 258 | 0.570 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 2004 | 357 | 0.510 |
Why?
|
| Urinary Bladder, Neurogenic | 3 | 2021 | 165 | 0.460 |
Why?
|
| Urogenital Abnormalities | 3 | 2021 | 261 | 0.440 |
Why?
|
| Nephrocalcinosis | 3 | 2017 | 48 | 0.410 |
Why?
|
| Kidney Cortex | 1 | 2011 | 186 | 0.400 |
Why?
|
| Meningomyelocele | 2 | 2021 | 165 | 0.350 |
Why?
|
| Kidney Transplantation | 6 | 2019 | 4251 | 0.320 |
Why?
|
| Urolithiasis | 2 | 2022 | 132 | 0.310 |
Why?
|
| Oxalates | 3 | 2022 | 105 | 0.310 |
Why?
|
| Kidney Calculi | 2 | 2022 | 465 | 0.280 |
Why?
|
| Sodium | 1 | 2011 | 1622 | 0.280 |
Why?
|
| Denys-Drash Syndrome | 1 | 2005 | 8 | 0.270 |
Why?
|
| Aquaporins | 3 | 2003 | 174 | 0.250 |
Why?
|
| Wilms Tumor | 1 | 2005 | 373 | 0.210 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2022 | 153 | 0.200 |
Why?
|
| Graft Survival | 5 | 2019 | 3734 | 0.200 |
Why?
|
| Infant | 20 | 2021 | 35122 | 0.180 |
Why?
|
| Living Donors | 2 | 2002 | 621 | 0.180 |
Why?
|
| Kidney Function Tests | 2 | 2020 | 684 | 0.180 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2019 | 51 | 0.170 |
Why?
|
| Kidney | 6 | 2021 | 7185 | 0.170 |
Why?
|
| Pedigree | 4 | 2020 | 4643 | 0.160 |
Why?
|
| Cations, Divalent | 1 | 1998 | 166 | 0.160 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2021 | 427 | 0.160 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2019 | 195 | 0.160 |
Why?
|
| Child | 26 | 2022 | 77637 | 0.150 |
Why?
|
| Body Water | 1 | 1998 | 343 | 0.150 |
Why?
|
| Minerals | 1 | 1998 | 267 | 0.150 |
Why?
|
| Hypertension, Renovascular | 1 | 1997 | 123 | 0.150 |
Why?
|
| Child, Preschool | 20 | 2022 | 40964 | 0.140 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 196 | 0.140 |
Why?
|
| RNA Interference | 2 | 2022 | 2890 | 0.140 |
Why?
|
| Infant, Newborn | 13 | 2021 | 25609 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1613 | 0.140 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2021 | 638 | 0.130 |
Why?
|
| Anion Transport Proteins | 1 | 2016 | 142 | 0.130 |
Why?
|
| Marfan Syndrome | 1 | 1997 | 240 | 0.130 |
Why?
|
| Dietary Proteins | 2 | 2011 | 962 | 0.130 |
Why?
|
| Mutation | 6 | 2020 | 29777 | 0.130 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 788 | 0.120 |
Why?
|
| Neurofibromatoses | 1 | 2018 | 299 | 0.120 |
Why?
|
| Nephrotic Syndrome | 1 | 2017 | 389 | 0.110 |
Why?
|
| Adolescent | 19 | 2020 | 85729 | 0.110 |
Why?
|
| Ion Channels | 1 | 1998 | 1056 | 0.110 |
Why?
|
| Urologic Surgical Procedures | 1 | 2015 | 301 | 0.110 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2012 | 42 | 0.110 |
Why?
|
| Epithelium | 1 | 2017 | 1679 | 0.110 |
Why?
|
| Amiloride | 1 | 2011 | 121 | 0.100 |
Why?
|
| Diet, Protein-Restricted | 1 | 2011 | 71 | 0.100 |
Why?
|
| Humans | 43 | 2022 | 743811 | 0.100 |
Why?
|
| Clinical Protocols | 1 | 2016 | 1459 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 288 | 0.090 |
Why?
|
| Male | 29 | 2022 | 349776 | 0.090 |
Why?
|
| Female | 26 | 2022 | 380020 | 0.090 |
Why?
|
| Kidney Medulla | 2 | 2001 | 182 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 17439 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2020 | 3024 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2020 | 2614 | 0.080 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2009 | 114 | 0.080 |
Why?
|
| Urodynamics | 2 | 2021 | 347 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2011 | 8300 | 0.080 |
Why?
|
| Diuretics | 1 | 2011 | 591 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 4260 | 0.080 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 378 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2022 | 12020 | 0.080 |
Why?
|
| Kidney Diseases | 2 | 2012 | 2146 | 0.080 |
Why?
|
| Graft Rejection | 4 | 2019 | 4398 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3645 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2020 | 8316 | 0.070 |
Why?
|
| Biological Transport | 1 | 2011 | 2119 | 0.070 |
Why?
|
| Nutritional Support | 1 | 2008 | 168 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2019 | 63042 | 0.070 |
Why?
|
| Registries | 6 | 2020 | 8090 | 0.070 |
Why?
|
| Aldosterone | 1 | 2011 | 877 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 3622 | 0.070 |
Why?
|
| Recurrence | 3 | 2004 | 8337 | 0.070 |
Why?
|
| Aquaporin 6 | 3 | 2003 | 45 | 0.070 |
Why?
|
| Fetal Development | 1 | 2011 | 767 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 1955 | 0.070 |
Why?
|
| Citric Acid | 1 | 2005 | 126 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2200 | 0.060 |
Why?
|
| Aquaporin 2 | 3 | 2003 | 148 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2019 | 4183 | 0.060 |
Why?
|
| Renal Dialysis | 3 | 2014 | 1783 | 0.060 |
Why?
|
| Dogfish | 1 | 2003 | 11 | 0.060 |
Why?
|
| Prospective Studies | 7 | 2021 | 53250 | 0.060 |
Why?
|
| Dihydrotachysterol | 1 | 2003 | 4 | 0.060 |
Why?
|
| Membranes, Artificial | 1 | 2005 | 371 | 0.060 |
Why?
|
| Rats | 5 | 2011 | 24250 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9648 | 0.060 |
Why?
|
| Calpain | 1 | 2003 | 150 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7270 | 0.050 |
Why?
|
| Calcium Oxalate | 1 | 2022 | 74 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2005 | 389 | 0.050 |
Why?
|
| Young Adult | 5 | 2020 | 56392 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2534 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3750 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2003 | 1081 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 3503 | 0.050 |
Why?
|
| Calcineurin | 1 | 2001 | 226 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
| Energy Intake | 1 | 2008 | 2149 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12209 | 0.050 |
Why?
|
| beta Carotene | 1 | 2022 | 527 | 0.050 |
Why?
|
| Hostility | 1 | 2021 | 189 | 0.050 |
Why?
|
| Cystine | 1 | 2020 | 95 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2022 | 2566 | 0.040 |
Why?
|
| Magnesium | 1 | 2003 | 813 | 0.040 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2019 | 103 | 0.040 |
Why?
|
| Adult | 11 | 2021 | 213889 | 0.040 |
Why?
|
| Animals | 11 | 2022 | 168660 | 0.040 |
Why?
|
| Prognosis | 4 | 2019 | 29052 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 491 | 0.040 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2019 | 153 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 2407 | 0.040 |
Why?
|
| Calcium, Dietary | 1 | 2022 | 525 | 0.040 |
Why?
|
| Calcium | 3 | 2022 | 5755 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 1620 | 0.040 |
Why?
|
| Aquaporin 3 | 1 | 1998 | 14 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 515 | 0.040 |
Why?
|
| Arginine Vasopressin | 1 | 1998 | 130 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 712 | 0.040 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2703 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2000 | 707 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 1998 | 112 | 0.040 |
Why?
|
| Hypertension | 1 | 2018 | 8480 | 0.040 |
Why?
|
| Heparin | 1 | 2005 | 1637 | 0.040 |
Why?
|
| Potassium | 1 | 2022 | 1336 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2016 | 1683 | 0.040 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2017 | 92 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 438 | 0.040 |
Why?
|
| Heredity | 1 | 2017 | 154 | 0.040 |
Why?
|
| Homeostasis | 2 | 2017 | 3337 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 1998 | 589 | 0.040 |
Why?
|
| Vasopressins | 1 | 1998 | 370 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2019 | 40545 | 0.030 |
Why?
|
| Phenotype | 3 | 2018 | 16361 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 1968 | 0.030 |
Why?
|
| Urea | 1 | 1998 | 450 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2017 | 275 | 0.030 |
Why?
|
| Ureter | 1 | 1998 | 375 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 1998 | 409 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2017 | 416 | 0.030 |
Why?
|
| Sulfates | 1 | 2016 | 390 | 0.030 |
Why?
|
| Bicarbonates | 1 | 2016 | 312 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2016 | 13809 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2018 | 646 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2017 | 375 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2017 | 3000 | 0.030 |
Why?
|
| Urography | 1 | 2015 | 313 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 3591 | 0.030 |
Why?
|
| Ureteroscopy | 1 | 2015 | 143 | 0.030 |
Why?
|
| Endosomes | 3 | 2003 | 518 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14563 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2017 | 5986 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2008 | 15281 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 2803 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2022 | 21733 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2020 | 1173 | 0.030 |
Why?
|
| Hemodialysis Solutions | 1 | 2012 | 8 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2298 | 0.030 |
Why?
|
| Risk Factors | 4 | 2022 | 72252 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 1129 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 10251 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 713 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 1998 | 2725 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 840 | 0.030 |
Why?
|
| Mice | 4 | 2022 | 81154 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 1171 | 0.030 |
Why?
|
| Protein Binding | 2 | 2020 | 9377 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2503 | 0.030 |
Why?
|
| Water | 1 | 1998 | 1394 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 2839 | 0.030 |
Why?
|
| Syndrome | 1 | 2018 | 3249 | 0.020 |
Why?
|
| Epitopes | 1 | 1998 | 2570 | 0.020 |
Why?
|
| Incidence | 2 | 2021 | 20948 | 0.020 |
Why?
|
| United States | 5 | 2020 | 69859 | 0.020 |
Why?
|
| Survival Rate | 3 | 2014 | 12786 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2634 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 2954 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12954 | 0.020 |
Why?
|
| Age of Onset | 1 | 2017 | 3268 | 0.020 |
Why?
|
| Fibrosis | 1 | 2017 | 2030 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2020 | 77410 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6934 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1988 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 29140 | 0.020 |
Why?
|
| Antibodies | 1 | 1998 | 2459 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2005 | 4599 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1775 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 4152 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3144 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 2865 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 1900 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1654 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 4459 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 5021 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 4009 | 0.020 |
Why?
|
| Hemofiltration | 1 | 2008 | 57 | 0.020 |
Why?
|
| Age Factors | 1 | 2004 | 18355 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2019 | 23327 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2971 | 0.020 |
Why?
|
| Critical Illness | 2 | 2009 | 2670 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3439 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9310 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 18107 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 7793 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20121 | 0.010 |
Why?
|
| Diet | 1 | 2022 | 7930 | 0.010 |
Why?
|
| Leupeptins | 1 | 2003 | 122 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14714 | 0.010 |
Why?
|
| Cell Line | 1 | 2017 | 15993 | 0.010 |
Why?
|
| Caseins | 1 | 2003 | 104 | 0.010 |
Why?
|
| Immune Sera | 1 | 2003 | 641 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18027 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12944 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 190 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2001 | 11 | 0.010 |
Why?
|
| Trypsin | 1 | 2003 | 511 | 0.010 |
Why?
|
| Demography | 1 | 2007 | 1653 | 0.010 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2008 | 981 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 2001 | 184 | 0.010 |
Why?
|
| Nephrons | 1 | 2003 | 220 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2005 | 549 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 2003 | 5973 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15067 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 1095 | 0.010 |
Why?
|
| Dextrans | 1 | 2003 | 595 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15526 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13273 | 0.010 |
Why?
|
| Autoradiography | 1 | 2001 | 745 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 9848 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6356 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 39001 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 11360 | 0.010 |
Why?
|
| Aging | 1 | 1998 | 8655 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 7729 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1800 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 15211 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2001 | 23398 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5952 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1802 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19894 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2001 | 1227 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 12243 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 3458 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2000 | 4777 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10940 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 1998 | 2167 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2001 | 8436 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 9139 | 0.000 |
Why?
|
| Middle Aged | 1 | 2014 | 213241 | 0.000 |
Why?
|
Concepts
(261)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_